Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats
Novo Nordisk has raised its offer to buy out obesity biotech Metsera to $10bn as a bidding war with Pfizer…
Tag: Metsera
Novo Nordisk CEO Doustdar on Headwinds, Metsera Bid, US Pricing
Novo Nordisk CEO Maziar Mike Doustdar discusses demand for the Danish firm’s weight-loss drug Wegovy and diabetes medication Ozempic. He…
Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle
Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo’s updated offer values Metsera at…
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war
Pfizer has followed through on its threats, filing a lawsuit against both Metsera and Novo Nordisk during a M&A bidding…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
(Reuters) -Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk , saying Metsera breached its…
Pfizer wins early US antitrust nod for Metsera deal
(Reuters) -Pfizer has received early U.S. antitrust clearance more than a week early for its proposed $7.3 billion Metsera acquisition,…
Pfizer Sues to Block Novo Bid for Obesity Drugmaker Metsera
Pfizer Inc. sued Metsera Inc. and rival drugmaker Novo Nordisk A/S to block the Danish company’s rival bid for the…
Pfizer Joins Obesity Drug Race With $5B Metsera Purchase
Pfizer will pay $4.9 billion for the obesity startup Metsera in a bid to catch up to rival drugmakers after…
Pfizer to buy weight-loss drug developer Metsera
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer on Monday said it would buy weight loss drugmaker…
Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal
Metsera’s shareholders could see significant bonuses if certain milestones are reached. www.marketwatch.com #Pfizer #billion #bet #obesity #drugs #Metsera #buyout #deal